Sort
30,917 grants matching “tumor microenvironment”
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$353,132Malay Haldar · University Of Pennsylvania · R37 · FY2024 · CA
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$353,107Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2024 · CA
Role of Bone in Primary and Metastatic Cancer
$353,076Roberta Faccio · Washington University · R01 · FY2023 · CA
Role of Bone in Primary and Metastatic Cancer
$353,076Roberta Faccio · Washington University · R01 · FY2022 · CA
Signal Transduction Therapy--Clinical
$353,072Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$353,055Lieping Chen · Yale University · P50 · FY2022 · CA
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
$353,044Kavitha Yaddanapudi · University Of Louisville · R01 · FY2025 · CA
Re-activating Memory T Cells in the Microenvironment of Human Tumors
$353,042Richard B Bankert · State University Of New York At Buffalo · R01 · FY2013 · CA
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
$352,995Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Defining the effects of bortezomib on NK cell activation in cancer
$352,838Anil Shanker · Meharry Medical College · SC1 · FY2014 · CA
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
$352,808Xiao-Jing Wang · University Of Colorado Denver · P50 · FY2021 · CA
Mechanisms coupling DEK to oncogenesis
$352,801Lisa M. Privette Vinnedge · Cincinnati Childrens Hosp Med Ctr · R37 · FY2019 · CA
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
$352,801Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2019 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$352,801Yi Lin · Mayo Clinic Rochester · R01 · FY2019 · CA
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
$352,778Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R37 · FY2023 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$352,757Hui Zhang · University Of Louisville · R01 · FY2025 · CA
Fatty Acid Synthase:Molecular Target for Breast Cancer Therapy & Chemoprevention
$352,699Ruth Lupu · Mayo Clinic Rochester · R01 · FY2008 · CA
Microenvironmental Regulation of Leukemia Stem Cells
$352,688Ravi Bhatia · University Of Alabama At Birmingham · R01 · FY2020 · CA
Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
$352,688Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2024 · CA
Microenvironmental Regulation of Leukemia Stem Cells
$352,688Ravi Bhatia · University Of Alabama At Birmingham · R01 · FY2019 · CA
Microenvironmental Regulation of Leukemia Stem Cells
$352,688Ravi Bhatia · University Of Alabama At Birmingham · R01 · FY2021 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$352,665Katherine B Chiappinelli · George Washington University · R37 · FY2024 · CA
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$352,660Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2023 · CA
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$352,660Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2022 · CA
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer
$352,657Saori Furuta · University Of Toledo Health Sci Campus · R01 · FY2020 · CA